Electro-Optical Sciences has signed a licensing agreement with KaVo Dental, a dental equipment manufacturer, to develop and commercialize Difoti®, a noninvasive imaging device developed by EOS for the detection of dental caries. 

“We are pleased that KaVo will be commercializing Difoti to realize its true  value in the high-tech dental arena,” says Joseph V. Gulfo, MD, president and CEO of EOS. “KaVo is known for its constant innovation  and we believe that their marketing expertise will allow for tremendous success  with Difoti. EOS remains focused on the development and commercialization of MelaFind, our noninvasive, point instrument to assist in the early diagnosis of melanoma.”   

In accordance with the terms of the agreement, KaVo will pay EOS an  undisclosed upfront sum as well as up to a double-digit annual royalty based on  the number of systems sold per calendar year. KaVo has made a multimillion  dollar commitment to refine the Difoti product for commercial launch.     
[KAVO, December 12, 2006]